Abstract
Abstract P39: CFT7455, a novel IKZF1/3 degrader enhances the anti-myeloma activity of monoclonal and bispecific antibodies by augmenting immune responses
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have